# FDA Inspection 1166306 - RenovoRx, Inc. - April 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/renovorx-inc/a3744e11-0422-4793-b1f6-94995dbbc6b9
Source feed: FDA_Inspections

> FDA Inspection 1166306 for RenovoRx, Inc. on April 04, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1166306
- Company Name: RenovoRx, Inc.
- Inspection Date: 2022-04-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Compliance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1166306 - 2022-04-04](https://www.keypedia.com/records/fda_inspections/renovorx-inc/80aa6985-678e-4c36-b682-fe8b47ee6f57)
- [FDA Inspection 978263 - 2016-05-18](https://www.keypedia.com/records/fda_inspections/renovorx-inc/427d1984-cb43-4361-9c81-b3e02f83351d)

Company: https://www.keypedia.com/companies/renovorx-inc/53ed9d73-0643-4791-8e37-cd5a04c834fd

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7